Top 5 Stocks to Buy Now
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel
LON:4BB

4basebio Interim Earnings Report

4basebio logo
GBX 550 +25.00 (+4.76%)
As of 06/19/2026 11:49 AM Eastern
ProfileEarnings HistoryForecast

4basebio EPS Results

Actual EPS
-GBX 50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

4basebio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

4basebio Announcement Details

Quarter
Interim
Date
9/29/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

4basebio Earnings Headlines

4basebio Sets Investor Presentation as It Advances Synthetic DNA Platform
June 16, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/4basebio-sets-investor-presentation-as-it-advances-synthetic-dna-platform?utm_source=marketbeat.com&utm_medium=referral
4basebio Plc - 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board
June 15, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-4basebio-appoints-dr-060000825.html
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
June 21 at 1:00 AM  |  Porter & Company (Ad)
4basebio appoints Johns Hopkins RNA expert to advisory board
June 15, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-appoints-johns-hopkins-rna-063200549.html
4basebio (LON:4BB) Shares Down 0.2% - Here's Why
June 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30836104
4basebio CEO Increases Stake with Market Purchase of Ordinary Shares
May 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/4basebio-ceo-increases-stake-with-market-purchase-of-ordinary-shares?utm_source=marketbeat.com&utm_medium=referral
See More 4basebio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 4basebio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 4basebio and other key companies, straight to your email.

About 4basebio

4basebio (LON:4BB) is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

View 4basebio Profile
Earnings Tools